These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7201810)

  • 1. A comparative study on the effect of dilazep and dipyridamole on some platelet functions.
    Valori VM; Leone G; Traisci G; Bizzi B
    Arzneimittelforschung; 1982; 32(4):403-5. PubMed ID: 7201810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of dilazep on circulating platelet aggregation in diabetics].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O; Manotti C
    Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dilazep (AS-05) on human blood platelet aggregation.
    Kuzuya F
    Arzneimittelforschung; 1979; 29(3):539-42. PubMed ID: 582740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
    Agarwal KC; Zielinski BA; Maitra RS
    Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dilazep on shape change of human erythrocyte in blood stored over a period of 42 days.
    Fujisawa Y; Abiko Y
    Arzneimittelforschung; 1981; 31(9):1462-8. PubMed ID: 7197956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD; Agarwal KC; Parks RE
    Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dilazep on decrease in myocardial pH during ischemia in dogs.
    Haga N; Miura I; Fujisawa Y; Fukushi Y; Abiko Y
    Arzneimittelforschung; 1986 Jun; 36(6):913-6. PubMed ID: 3741523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
    Zhou H
    Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dilazep on platelet aggregation.
    Nakajima K; Shirai K; Takimoto M; Satoh F; Aoki M
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1899-901. PubMed ID: 4480271
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus.
    Ozaki Y; Jinnai Y; Yatomi Y; Tawata M; Onaya T; Kume S
    Arzneimittelforschung; 1993 May; 43(5):536-9. PubMed ID: 8392344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
    Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adenosine degradation in human erythrocytes in the presence of dilazep].
    Blum KU; Merkel R
    Arzneimittelforschung; 1976; 26(9):1638-42. PubMed ID: 1036691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function in pregnant women receiving aspirin and dipyridamole.
    Kinouchi K; Fujita T; Narahara C; Kitamura S
    J Anesth; 2000; 14(3):115-8. PubMed ID: 14564576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dilazep on human platelets and rat vascular tissue: in vitro studies on platelet aggregation, and arachidonic acid oxidation.
    Colli S; Maderna P; Morazzoni G; Speroni C; Tremoli E
    Pharmacol Res Commun; 1983 Jun; 15(6):593-602. PubMed ID: 6412253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of adenosine 5'-diphosphate (ADP)- and collagen-induced platelet aggregation in canine leishmaniasis.
    Pelagalli A; Ciaramella P; Lombardi P; Pero ME; Cortese L; Corona M; Oliva G; Avallone L
    J Comp Pathol; 2004; 130(2-3):124-9. PubMed ID: 15003469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the bioavailability of the individual components from a combination of dilazep and beta-acetyldigoxin (author's transl)].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1976; 26(12):2208-13. PubMed ID: 1037278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.